IMARC Group, a leading market research company, has recently releases report titled “Cannula Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global cannula market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the cannula market?

The global cannula market size reached US$ 149.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 219.1 Million by 2028, exhibiting a growth rate (CAGR) of 7.1% during 2023-2028.

What is cannula?

A cannula can be defined as a hollow, flexible tube with a sharp, retractable inner core that can be inserted into a vein, body cavity or artery. It is used to remove fluids or gather samples from the body or deliver fluids to the body. There are different kinds of cannulas available for a range of procedures in different sizes. Cannulas are now also being used over hypodermic needles for injecting fillers due to their associated benefits like greater flexibility, less risk of bruising or bleeding, and reduced pain. As a result, they find applications in blood banks, hospitals, pathology labs, and ambulatory surgery centers (ASCs).

Request for a sample copy of this report: https://www.imarcgroup.com/cannula-market/requestsample

What are the growth prospects and trends in the cannula industry?

One of the major factors impelling the market growth is the continuing spread of the coronavirus disease (COVID-19). The pandemic has led to a spike in the hospitalization of the affected patients, which, in turn, has stimulated the demand for cannulas. Apart from this, the rising cases of cardiovascular diseases over the past decade and the increasing inclination toward minimally invasive surgeries (MIS) are also contributing to the market growth. Furthermore, several manufacturers are introducing advanced cannulas, which is creating a positive outlook for the market.

For instance, Uni-flo2 Single Nasal Cannula by UPODS, LLC and 3B Medical’s Freedom X oxygen cannula are designed to offer maximum comfort to the patients while receiving oxygen. Similarly, Medtronic has launched Kyphon Cannula in 2020 for balloon kyphoplasty surgeries in the United States. Some of the other factors bolstering the market growth are the rising popularity of cosmetic surgeries, increasing advancements in medical sciences, and favorable government policies for offering primary healthcare services. 

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

• Cardiac Cannulas
• Nasal Cannulas
• Vascular Cannulas
• Dermatology Cannulas
• Arthroscopy Cannulas
• Others

Breakup by Type:

• Neonatal Cannulas
• Straight Cannulas
• Winged Cannula
• Wing with Port Cannula
• Others

Breakup by Size:

• 14G
• 16G
• 18G
• 20G
• 22G
• 24G
• 26G

Breakup by Material:

• Plastic (PVC) Cannulas
• Silicone Cannulas
• Metal Cannulas (Stainless Steel)

Breakup by Application:

• Cardiovascular Surgery
• Oxygen Therapy
• General Surgery
• Cosmetic/Plastic Surgery
• Orthopedic Surgery
• Others

Breakup by End-User:

• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Others

Breakup by Region:

• North America (U.S. & Canada)
• Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
• Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
• Latin America (Brazil, Mexico)
• Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• Boston Scientific Corporation
• CONMED Corporation
• Edwards Lifesciences
• Medtronic Plc
• Smith & Nephew PLC
• Smiths Medical Inc
• LivaNova Plc
• Teleflex Incorporated
• Terumo Corporation

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal